Annual Accounts Payable
$1.42 M
+$1.32 M+1334.04%
December 31, 2023
Summary
- As of February 8, 2025, COEP annual accounts payable is $1.42 million, with the most recent change of +$1.32 million (+1334.04%) on December 31, 2023.
- During the last 3 years, COEP annual accounts payable has fallen by -$204.10 thousand (-12.57%).
- COEP annual accounts payable is now -12.57% below its all-time high of $1.62 million, reached on December 1, 2020.
Performance
COEP Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.13 M
-$147.00 K-11.47%
September 1, 2024
Summary
- As of February 8, 2025, COEP quarterly accounts payable is $1.13 million, with the most recent change of -$147.00 thousand (-11.47%) on September 1, 2024.
- Over the past year, COEP quarterly accounts payable has dropped by -$285.50 thousand (-20.11%).
- COEP quarterly accounts payable is now -20.11% below its all-time high of $1.42 million, reached on December 31, 2023.
Performance
COEP Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
COEP Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1334.0% | -20.1% |
| 3 y3 years | -12.6% | +322.4% |
| 5 y5 years | -12.6% | +322.4% |
COEP Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1334.0% | -20.1% | +1045.7% |
| 5 y | 5-year | -12.6% | +1334.0% | -20.1% | +1045.7% |
| alltime | all time | -12.6% | +1334.0% | -20.1% | +1045.7% |
Coeptis Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.13 M(-11.5%) |
| Jun 2024 | - | $1.28 M(-6.2%) |
| Mar 2024 | - | $1.37 M(-3.8%) |
| Dec 2023 | $1.42 M(+1334.0%) | $1.42 M(+194.5%) |
| Sep 2023 | - | $482.00 K(+22.0%) |
| Jun 2023 | - | $395.20 K(+63.0%) |
| Mar 2023 | - | $242.50 K(+144.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $99.00 K(-26.2%) | $99.00 K(-69.8%) |
| Sep 2022 | - | $327.90 K(+22.1%) |
| Jun 2022 | - | $268.50 K(+9.7%) |
| Mar 2022 | - | $244.80 K(+82.6%) |
| Dec 2021 | $134.10 K(-91.7%) | - |
| Dec 2021 | - | $134.10 K |
| Dec 2020 | $1.62 M | - |
FAQ
- What is Coeptis Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Coeptis Therapeutics?
- What is Coeptis Therapeutics annual accounts payable year-on-year change?
- What is Coeptis Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Coeptis Therapeutics?
- What is Coeptis Therapeutics quarterly accounts payable year-on-year change?
What is Coeptis Therapeutics annual accounts payable?
The current annual accounts payable of COEP is $1.42 M
What is the all time high annual accounts payable for Coeptis Therapeutics?
Coeptis Therapeutics all-time high annual accounts payable is $1.62 M
What is Coeptis Therapeutics annual accounts payable year-on-year change?
Over the past year, COEP annual accounts payable has changed by +$1.32 M (+1334.04%)
What is Coeptis Therapeutics quarterly accounts payable?
The current quarterly accounts payable of COEP is $1.13 M
What is the all time high quarterly accounts payable for Coeptis Therapeutics?
Coeptis Therapeutics all-time high quarterly accounts payable is $1.42 M
What is Coeptis Therapeutics quarterly accounts payable year-on-year change?
Over the past year, COEP quarterly accounts payable has changed by -$285.50 K (-20.11%)